Fibrodysplasia Ossificans Progressiva (FOP)

Robert J. Pignolo, MD, Professor at Mayo Clinic, Rochester, MN, discusses fibrodysplasia ossificans progressiva (FOP), a rare genetic disorder characterized by the organization of heterotopic hard tissues within the soft tissues, such as ligaments, tendons, and...

Diagnosing Myasthenia Gravis

Gordon Smith, MD, Professor and Chair of Neurology, Virginia Commonwealth University, gives advice on raising awareness and diagnosing myasthenia gravis.       Transcription: It’s challenging to provide education for primary care around diseases...

Phase 2 NOBLE Study

Andrew Bomback, MD, Columbia University Medical Center, discusses the Phase 2 NOBLE study, testing pegcetacoplan in patients with immune-complex MPGN or C3 glomerulopathy.       Transcription:  The NOBLE study is a really interesting study because what...

CIDP and Efgartigimod

Richard Lewis, MD, Department of Neurology, Cedars-Sinai Medical Center, explains CIDP and efgartigimod, a new treatment that targets FcRn.       Transcription: My name is Richard Lewis. I’m a Professor of Neurology at Cedar-Sinai Medical Center...

Myasthenia Gravis Patient Inequalities

Gordon Smith, MD, Professor and Chair of Neurology, Virginia Commonwealth University, explains how the current healthcare system leads to inequalities in diagnosis and treatment of myasthenia gravis.     Transcription: I’m Gordon Smith. I’m a...